Probiotics for Diaper Dermatitis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Diaper Dermatitis

In brief

The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years? Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups. Participants will: * receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.

Key facts

Study ID

NCT06755307

Run by

University Maribor

People needed

42

Starts

2025-08-14

Expected to finish

2026-03-01

Last updated by the study team

2025-11-24

Who can join

Age: 0 and older, up to 2. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• presence of diaper dermatitis
• age less than two years

You may not qualify if…

• previous use of probiotics
• age more than two years
• an acute bacterial infection
• chronic disease
• local use of antibiotics in the anogenital region

Where it is running

• University of Maribor, Faculty of Health Sciences — Maribor, Slovenia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.